SELENBP1 and breast carcinoma: As shown in Fig. 3A, the expression level of SELENBP1 in ER– breast cancer tissues was significantly lower than in ER+ tissues (4.44±2.62 versus 6.61±1.28, p = 0.000) (Fig. 3A and B).